| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a Universitätsklinikum Carl Gustav Carus, Med. Klinik I, Dresden, Germany;
b In-vitro Systems GmbH, Osterode, Germany
Key Words. Cord blood • Expansion • Feeder layer • MGDF • CD34 selection
Dr. Martin Bornhäuser, Medical Clinic I, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307 Dresden, Germany.
Ex vivo expansion of human umbilical cord blood cells (HUCBC) is explored by several investigators to enhance the repopulating potential of HUCBC.
We performed experiments using either Ficoll-separated or CD34+-selected HUCBC from the same donation in serum-free medium. CD34-purified HUCBC were cultured on either human umbilical vein endothelial cells (HUVEC) or irradiated bone marrow-derived stroma cells (BMSC) with addition of different cytokines. In addition, we tested the expansion of HUCBC in culture vessels with continuous rotation.
CD34 enrichment led to a significant increase in the expansion factor of CD34+ cells compared with unmanipulated HUCBC. BMSC were more efficient in amplifying early progenitors than HUVEC. Optimum results were reached by a combination of SCF, FLT-3L at 300 ng/ml and IL-3 at 50 ng/ml. No significant improvement in the expansion of CD34+/38– primitive progenitors could be obtained with other combinations. Addition of megakaryocyte-derived growth and development factor to each growth factor cocktail improved the expansion results. Continuous rotation of culture vessels did not ameliorate the expansion rate of the analyzed subsets. Culture conditions separating stroma and HUCBC by a semipermeable membrane improved the expansion factors of CD34+, CD34+/38–, and CD34+/41+ cells and CFU-GM compared with contact cultures. These data might be useful when designing culture systems for clinical scale ex vivo expansion of HUCBC.
This article has been cited by other articles:
|
|
 |
|
  J. Oswald, C. Steudel, K. Salchert, B. Joergensen, C. Thiede, G. Ehninger, C. Werner, and M. Bornhauser Gene-Expression Profiling of CD34+ Hematopoietic Cells Expanded in a Collagen I Matrix Stem Cells, March 1, 2006; 24(3): 494 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van Grevenynghe, M. Bernard, S. Langouet, C. Le Berre, T. Fest, and O. Fardel Human CD34-Positive Hematopoietic Stem Cells Constitute Targets for Carcinogenic Polycyclic Aromatic Hydrocarbons J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 693 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, C. A. Hart, J. Chang, and N. G. Testa AC133+ G0 Cells from Cord Blood Show a High Incidence of Long-Term Culture-Initiating Cells and a Capacity for More Than 100 Million-Fold Amplification of Colony-Forming Cells In Vitro Stem Cells, September 1, 2004; 22(5): 704 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jaroscak, K. Goltry, A. Smith, B. Waters-Pick, P. L. Martin, T. A. Driscoll, R. Howrey, N. Chao, J. Douville, S. Burhop, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System Blood, June 15, 2003; 101(12): 5061 - 5067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dravid and S.G.A. Rao Ex Vivo Expansion of Stem Cells from Umbilical Cord Blood: Expression of Cell Adhesion Molecules Stem Cells, March 1, 2002; 20(2): 183 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, J. Chang, and N. G. Testa Cord Blood G0 CD34+ Cells Have A Thousand-Fold Higher Capacity For Generating Progenitors In Vitro Than G1 CD34+ Cells Stem Cells, November 1, 2001; 19(6): 505 - 513. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
